Back to FATE
D. E. Shaw & Co., Inc. FATE Position History
Fate Therapeutics, Inc. • Healthcare
Quarters held
19
Latest value
$31K
Q1 2025
Peak value
$20M
First seen
Q4 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2022 | $2.6M |
| Q1 2023 | $16.1M |
| Q1 2023 | $773K |
| Q2 2023 | $20M |
| Q2 2023 | $1.9M |
| Q3 2023 | $9.1M |
| Q3 2023 | $856K |
| Q4 2023 | $11.4M |
| Q4 2023 | $2M |
| Q1 2024 | $14.8M |
| Q1 2024 | $5.2M |
| Q2 2024 | $10.7M |
| Q2 2024 | $2.7M |
| Q3 2024 | $9.8M |
| Q3 2024 | $2M |
| Q4 2024 | $1.8M |
| Q4 2024 | $727K |
| Q1 2025 | $312K |
| Q1 2025 | $31K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q1 2025 | $31K | 38.9K | — | — |
| Q1 2025 | $312K | 394.3K | — | — |
| Q4 2024 | $727K | 440.5K | — | — |
| Q4 2024 | $1.8M | 1.10M | — | — |
| Q3 2024 | $2M | 580.8K | — | — |
| Q3 2024 | $9.8M | 2.80M | — | — |
| Q2 2024 | $2.7M | 827.4K | — | — |
| Q2 2024 | $10.7M | 3.25M | — | — |
| Q1 2024 | $5.2M | 713.8K | — | — |
| Q1 2024 | $14.8M | 2.02M | — | — |
| Q4 2023 | $2M | 524.1K | — | — |
| Q4 2023 | $11.4M | 3.06M | — | — |
| Q3 2023 | $856K | 403.8K | — | — |
| Q3 2023 | $9.1M | 4.31M | — | — |
| Q2 2023 | $1.9M | 405.5K | — | — |
| Q2 2023 | $20M | 4.19M | — | — |
| Q1 2023 | $773K | 135.7K | — | — |
| Q1 2023 | $16.1M | 2.83M | — | — |
| Q4 2022 | $2.6M | 257.9K | — | — |
Other funds holding FATE
$39.7M
$31.3M
$22.5M
$18.5M
$18.4M